
Blog
ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors | Nature Immunology
Immunotherapy, particularly CAR T-Cell cancer therapy, extends the lives of
Immunotherapy, particularly CAR T-Cell cancer therapy, extends the lives of
Immunotherapy is an essential component of cancer treatment. However, despite
Researchers have engineered stem cells that do not generate dangerous
Despite its phylogenetic placement with DNA-targeting nucleases, Cas12a2 targets and
As CAR T-cell therapies have gained approvals in relapsed/refractory mantle
One of the challenges of CAR T cell therapy in
The accumulation of fat in the liver is an increasingly
Multiple myeloma is difficult to treat because of the heterogeneity
Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy that